CD74 and COVID-19: Finally, to explore the translational relevance of our findings, we assessed CD74 and CXCR4 surface expression in T cells and monocytes isolated from patients with mild (WHO 1–3) and severe (WHO grade ≥ 5) COVID-19 disease, which were obtained from the COVID-19 Registry of the LMU University Hospital Munich (CORKUM).